Michael J. Ostacher, MD, MPH
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California; The University of Chicago, Chicago, Illinois (Isaac, Radovan); Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, Palo Alto, California
Original Research
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
January 12, 2026
Innovation in psychiatric drug development in the past 13 years was limited, with most new drugs representing incremental advances rather than groundbreaking innovations.
Consensus Statement
Synopsis of the VA/DOD Clinical Practice Guideline for Management of Bipolar Disorder
January 13, 2025
This synopsis focuses on clinically relevant recommendations related to identification and management of bipolar disorder, including the acute and maintenance phases of illness.
